Revascularization of AMI Patients Persists Despite No Demonstrated Benefit
He said the U.S. "must heed the call to professional responsibility aimed at the elimination of tests and treatments that do not result in any benefit for our patients, and for which the net effects will be added costs, waste, and possible harm."
Hochman said that for now, physicians should become more diligent about doing what's in the best interests of patients. "It's incumbent on them to take it upon themselves to stop doing procedures with no demonstrated benefit so that we can bring down healthcare costs before some expert body, like a health insurance company says we're not going to reimburse for it.
- As Medicare Advantage Cuts Loom, Disagreement Over Program's Stability
- 3 Management Lessons from a Supermarket Debacle
- Medicare Advantage Carriers See 'No Choice' But to Accept Cuts
- Physicians to Appeal 'Docs v. Glocks' Ruling in FL
- CA Fines 8 Hospitals for Medical Errors
- Centralizing the Revenue Cycle Protects the Bottom Line
- Revenue Cycles Get a Boost from Simple JPEG Files
- IOM Identifies GME Problems, Calls for Finance Changes
- Employers Weigh Risks, Benefits of Private Exchanges
- Doctors Feel Pressure to Accept Risk-based Reimbursement